
Regeneron Pharmaceuticals, Inc. (REGN) Presents at Truist Securities BioPharma Symposium (Transcript)
Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Truist Securities BioPharma Symposium November 8, 2023 3:20 PM ET Company Participants Dr. Len Schleifer – President and Chief Executive